We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

By LabMedica International staff writers
Posted on 04 Jul 2025

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. More...

Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric leukemia under Europe’s IVDR framework. Now available for clinical use, this test enhances diagnostic accuracy, enabling more personalized treatment and better outcomes for children with this common cancer. This unique and new test is set to reshape the way BCP-ALL samples can be analyzed. It includes both gene expression subtype classification of B-cell leukemias and gene fusion analysis support.

The regulatory approved test benefits from machine learning based subtype classification with enhanced subtype coverage and reduces the risk of escalated and expensive treatments. An additional 7% of samples are subtyped using gene expression profiles, enabling detection of DUX4-rearranged and ETV6::RUNX1-like subtypes. The BCP-ALL test simplifies lab work by utilizing standard wetlab and standard kits, while combining gene expression-based subtyping and gene fusions in one clinical report. The robust test utilizes up to three different gene fusion callers for improved coverage, and gene fusions are presented in Tiers including all detected fusions.

The cost-effective test can replace FISH tests with significant cost savings. Additionally, Whole Transcriptome Sequencing (WTS) allows all fusions to be clinically annotated, with future updates in software rather than in lab workflows. By integrating advanced genetic analysis with user-friendly software, the test empowers diagnostic laboratories and clinicians to make informed decisions for enhanced patient care.

Related Links:
Qlucore 


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.